Truffle Hound Capital LLC Acquires New Shares in Kewaunee Scientific Co. (NASDAQ:KEQU)

Truffle Hound Capital LLC bought a new position in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,000 shares of the technology company’s stock, valued at approximately $619,000. Truffle Hound Capital LLC owned approximately 0.35% of Kewaunee Scientific at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in KEQU. IFP Advisors Inc acquired a new position in Kewaunee Scientific during the 4th quarter worth approximately $36,000. JPMorgan Chase & Co. increased its holdings in shares of Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after buying an additional 900 shares in the last quarter. Morgan Dempsey Capital Management LLC bought a new position in shares of Kewaunee Scientific in the 4th quarter valued at $106,000. Barclays PLC acquired a new stake in shares of Kewaunee Scientific during the 3rd quarter valued at $121,000. Finally, Janney Montgomery Scott LLC bought a new stake in Kewaunee Scientific during the 4th quarter worth $338,000. Institutional investors own 32.69% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.

Kewaunee Scientific Stock Down 6.0 %

NASDAQ:KEQU opened at $46.50 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. Kewaunee Scientific Co. has a one year low of $30.82 and a one year high of $71.33. The firm’s 50 day simple moving average is $57.46 and its 200 day simple moving average is $47.75. The company has a market cap of $132.76 million, a PE ratio of 7.37 and a beta of 0.71.

Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%. The business had revenue of $67.17 million during the quarter.

Insider Activity at Kewaunee Scientific

In other news, CEO Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $60.08, for a total value of $82,189.44. Following the completion of the transaction, the chief executive officer now directly owns 41,129 shares of the company’s stock, valued at approximately $2,471,030.32. This trade represents a 3.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Donald T. Gardner III sold 2,049 shares of the company’s stock in a transaction dated Tuesday, December 24th. The shares were sold at an average price of $58.19, for a total value of $119,231.31. Following the sale, the chief financial officer now owns 22,615 shares in the company, valued at approximately $1,315,966.85. The trade was a 8.31 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 10,144 shares of company stock worth $629,216 over the last ninety days. Insiders own 14.20% of the company’s stock.

Kewaunee Scientific Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.